fingolimod hydrochloride has been researched along with Delayed Effects, Prenatal Exposure in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baghbanian, SM; Cheraghmakani, H; Nasehi, MM | 1 |
| Alwan, S; Dahlgren, L; Lu, E; Sadovnick, AD; Synnes, A; Tremlett, H; Wang, BW | 1 |
| Aguilera, C; Tintoré, M; Tur, C | 1 |
| Gardner, NM; Gelineau-van Waes, J; Maddox, JR; Rainey, MA; Riley, RT; Sachs, AJ; Voss, KA; Wilberding, JD | 1 |
1 review(s) available for fingolimod hydrochloride and Delayed Effects, Prenatal Exposure
| Article | Year |
|---|---|
A review of safety-related pregnancy data surrounding the oral disease-modifying drugs for multiple sclerosis.
Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Crotonates; Dimethyl Fumarate; Female; Fingolimod Hydrochloride; Fumarates; Humans; Hydroxybutyrates; Immunologic Factors; Multiple Sclerosis; Nitriles; Pregnancy; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Propylene Glycols; Sphingosine; Toluidines | 2014 |
3 other study(ies) available for fingolimod hydrochloride and Delayed Effects, Prenatal Exposure
| Article | Year |
|---|---|
Neurodevelopmental retardation in a baby born to a multiple sclerosis patient being treated with fingolimod.
Topics: Child, Preschool; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Infant, Newborn; Intellectual Disability; Multiple Sclerosis; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Prenatal Exposure Delayed Effects | 2019 |
[Disease modifying drugs in multiple sclerosis and pregnancy].
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Antibodies, Monoclonal, Humanized; Female; Fingolimod Hydrochloride; Glatiramer Acetate; Humans; Immunologic Factors; Immunosuppressive Agents; Infant, Newborn; Interferon-beta; Multiple Sclerosis; Natalizumab; Peptides; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Propylene Glycols; Sphingosine; Stillbirth | 2012 |
Increased sphingoid base-1-phosphates and failure of neural tube closure after exposure to fumonisin or FTY720.
Topics: Animals; Cells, Cultured; Embryo, Mammalian; Female; Fingolimod Hydrochloride; Fumonisins; Mice; Mice, Inbred Strains; Models, Biological; Neural Tube Defects; Pregnancy; Prenatal Exposure Delayed Effects; Propylene Glycols; Sphingosine; Up-Regulation | 2012 |